Alopecia Areata Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years or older and have been diagnosed with stage 1, 2, or 3 breast cancer
- Your doctor has decided that chemotherapy before or after surgery is the right treatment for you, and you have not yet started any cancer treatment
- You are scheduled to receive at least 4 cycles of chemotherapy through a drip (IV), using one of the specific drug combinations listed in the trial (confirm with trial site for the full list)
- Your head size falls within the range that fits the device used in this study (confirm with trial site)
- Your chemotherapy is planned to be completed within 12 months
- You are willing and able to give your signed agreement to take part
- You are willing to wear the study device on your head before, during, and for 2 to 4 hours after each chemotherapy session
- You are willing to fill in questionnaires and have photos taken of your head at each visit
Who may not be able to join:
- You already have some hair loss before starting the trial
- You have a history of an autoimmune condition that causes hair loss, such as alopecia areata or lupus
- You have previously had radiation treatment to your whole brain
- You had chemotherapy within the last 2 years that caused hair loss
- You are currently taking or planning to take hormone or anti-estrogen therapy that is known to cause hair loss during the study period
- Your chemotherapy plan involves receiving both a taxane and an anthracycline drug on the same day
- You are pregnant (a pregnancy test will be done before you start, as is standard for chemotherapy patients)
- You have a known or suspected allergy to any part of the device that touches your skin
- You have a history of jaw joint disorder (Temporomandibular Joint Disorder)
- You have open wounds or sores on your scalp or face where the device would be placed that are not expected to heal before chemotherapy starts
- You have a serious infection or other serious illness that could prevent you from completing your chemotherapy
- You have another life-threatening cancer at the same time
- You have cancer that has spread to your scalp, or this is suspected
- You are already using a cold cap or any other device aimed at reducing hair loss
- In your doctor's opinion, joining this trial would not be appropriate or safe for you
- You are not able to keep to the schedule or follow the study requirements, physically or mentally
- You are currently in, or have been in within the last 30 days, another clinical trial that could cause hair loss
- You have taken part in this same trial before
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +1 (713) 855-3775
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Success in hair preservation using the Lily device after 4 cycles of chemotherapy, where hair preservation is defined as CTCAE v5.0 grade ≤ 1 alopecia determined by an independent healthcare professional.; Primary Safety Endpoint - Subject incidence of Grade 1 or above ADE, graded with Common Terminology Criteria for Adverse Events (CTCAE) v5.0.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.